The Nasdaq Composite added 196.73 points, or 1.26%, at 15,850.10
Merck's at-home Covid-19 pill gets US approval; weekly jobless claims unchanged at 205,000
Heavyweight tech shares fall, financials erase gains; Oracle falls on report co in talks to buy Cerner
Chairman Gary Gensler cites the 'dash for cash' among investors at start of the pandemic
US consumer prices increase further in November; Oracle leaps on upbeat quarterly results, outlook
Intel jumps on plans to list self-driving car unit while Merck slips on pausing enrollment in HIV-1 trials; travel shares join rebound
Boeing gains on progress towards China approval of 737 MAX * Apple falls after report of slowing iPhone 13 demand
Merck up as FDA panel narrowly votes to back Covid pill; payrolls, factory activity increase in November
The Dow Jones Industrial Average fell 652.22 points, or 1.86%, to 34,483.72
The S&P 500 was down 86.05 points, or 1.83%, at 4,615.41 and the Nasdaq Composite was down 214.71 points, or 1.36%, at 15,630.52
Financials rally on rate hike expectations; Nasdaq hits second consecutive record high
Nasdaq closed at a new record high Friday, but blue-chip US stocks and oil sank amid renewed concerns about COVID-19 that boosted safe havens like the dollar
Travel stocks slump as European Covid cases rise; Stay-at-home stocks gain
As part of Freshworks Startup Program, companies can get going with up to $3,000 in credits for Freshstack
The Dow Jones Industrial Average was down 89.73 points, or 0.25%, at 36,067.85
The Dow Jones Industrial Average rose 89.08 points, or 0.25%, to 35,819.56
Amazon.com, Apple fall in late trade after quarterly reports; Caterpillar, Merck rise after posting higher profits
Dow down 0.74%, S&P 500 down 0.51%, Nasdaq unchanged
Intel slammed after Q3 sales miss; Facebook falls on Apple privacy worries
The S&P 500 gained 15.01 points, or 0.34%, to 4,486.38 and the Nasdaq Composite added 124.47 points, or 0.84%, to 15,021.81